JUEPX
Price
$26.16
Change
+$0.23 (+0.89%)
Updated
Jul 3 closing price
Net Assets
32.68B
RWEBX
Price
$64.15
Change
+$0.53 (+0.83%)
Updated
Jul 3 closing price
Net Assets
202.05B
Interact to see
Advertisement

JUEPX vs RWEBX

Header iconJUEPX vs RWEBX Comparison
Open Charts JUEPX vs RWEBXBanner chart's image
JPMorgan US Equity R3
Price$26.16
Change+$0.23 (+0.89%)
VolumeN/A
Net Assets32.68B
American Funds Washington Mutual R2E
Price$64.15
Change+$0.53 (+0.83%)
VolumeN/A
Net Assets202.05B
JUEPX vs RWEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JUEPX vs. RWEBX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JUEPX is a StrongBuy and RWEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWEBX has more cash in the bank: 202B vs. JUEPX (32.7B). RWEBX pays higher dividends than JUEPX: RWEBX (0.80) vs JUEPX (0.22). JUEPX was incepted earlier than RWEBX: JUEPX (9 years) vs RWEBX (11 years). RWEBX (1.06) is less costly to investors than JUEPX (0.97). JUEPX is a more actively managed with annual turnover of: 53.00 vs. RWEBX (31.00). JUEPX has a lower initial minimum investment than RWEBX: JUEPX (0) vs RWEBX (250). RWEBX (7.02) and JUEPX (6.72) have marching annual gain over last year. JUEPX return over 5 years is better than : 62.62 vs. RWEBX (52.48).
JUEPXRWEBXJUEPX / RWEBX
Total Expense Ratio0.941.0689%
Annual Report Gross Expense Ratio0.971.0692%
Fund Existence9 years11 years-
Gain YTD6.4675.319122%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets32.7B202B16%
Annual Yield % from dividends0.220.8028%
Returns for 1 year6.727.0296%
Returns for 3 years50.3029.59170%
Returns for 5 years62.6252.48119%
Returns for 10 yearsN/A65.56-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLK1.780.07
+4.09%
Outlook Therapeutics
GLRE14.320.17
+1.20%
Greenlight Capital Re Ltd
RGEN127.470.51
+0.40%
Repligen Corp
TGI25.820.09
+0.35%
Triumph Group
NUWE0.20-0.02
-10.57%
Nuwellis Inc